IGF1R and ovarian carcinoma: While an earlier study reported that of 80 ovarian cancer cases (FIGO I–IV), only 9 (11%) of patients were IGF-1R positive [71], more recent studies have shown that IGF-1R expression was high (>50%) particularly in high-grade ovarian cancer cases [72–74].